These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9089230)

  • 1. Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods.
    Rodey GE; Revels K; Fuller TC
    Transplantation; 1997 Mar; 63(6):885-93. PubMed ID: 9089230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients.
    Rodey GE; Neylan JF; Whelchel JD; Revels KW; Bray RA
    Hum Immunol; 1994 Apr; 39(4):272-80. PubMed ID: 7520897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-specific HLA class I and CREG antibodies in complement-dependent cytotoxicity-negative renal transplants.
    Kim Y; Yang CW; Moon IS; Kim M; Lim J; Park YJ; Han K; Oh EJ
    Ann Clin Lab Sci; 2010; 40(4):330-5. PubMed ID: 20947806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epitope analysis of HLA class I donor specific antibodies in sensitized renal transplant recipients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Kostakis A; Stavropoulos-Giokas C
    Transplantation; 2000 Jul; 70(2):323-7. PubMed ID: 10933158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience on identification of cross-reactive group specificity performed by anti-human globulin panel reactive antibody tests].
    Sohn YH; Cha CH; Kim MH; Ko SY; Oh HB
    Korean J Lab Med; 2008 Oct; 28(5):362-70. PubMed ID: 18971617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
    Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
    Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to private and public HLA class I epitopes in platelet recipients.
    Zimmermann R; Wittmann G; Zingsem J; Blasczyk R; Weisbach V; Eckstein R
    Transfusion; 1999 Jul; 39(7):772-80. PubMed ID: 10413287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of HLA-class I alloantibodies using PRA-STAT and complement-dependent cytotoxicity techniques.
    Papassavas AC; Iniotaki-Theodoraki A; Stathakopoulou A; Ioannou S; Kostakis A; Stavropoulos-Giokas C
    Transplant Proc; 1998 May; 30(3):724-6. PubMed ID: 9595073
    [No Abstract]   [Full Text] [Related]  

  • 10. A limited number of HLA epitopes are recognized from HLA class I-specific antibodies detected in the serum of sensitized patients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Douramani P; Kostakis A; Stavropoulos-Giokas C
    Hum Immunol; 2000 Jul; 61(7):705-10. PubMed ID: 10880741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of HLA class I specific antibodies in patients with failed allografts.
    Mao Q; Terasaki PI; Cai J; El-Awar N; Rebellato L
    Transplantation; 2007 Jan; 83(1):54-61. PubMed ID: 17220791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
    Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of anti-HLA-antibodies against intra-CREG-mismatches in renal transplant recipients.
    Papassavas AC; Iniotaki-Theodoraki A; Boletis J; Kostakis A; Stavropoulos-Giokas C
    Transplant Proc; 1999; 31(1-2):757-9. PubMed ID: 10083324
    [No Abstract]   [Full Text] [Related]  

  • 15. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
    İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
    Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
    Papassavas AC; Barnardo MC; Bunce M; Welsh KI
    Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of HLA class I- and class II-specific antibodies by flow cytometry and PRA-STAT screening in renal transplant recipients.
    Harmer AW; Heads AJ; Vaughn RW
    Transplantation; 1997 Jun; 63(12):1828-32. PubMed ID: 9210512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.